Researchers conducted a cohort study to assess the effect of incretin receptor agonist therapy on continuous positive airway pressure use in T2D, obesity, and OSA.
India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results